Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal barrier is a multi-component system that serves as the primary interface between the host and the external environment of the gut lumen. It consists of a physical barrier formed by a single layer of intestinal epithelial cells connected by tight junction proteins (such as claudins and occludin), a chemical barrier comprising a thick mucus layer and antimicrobial peptides, and an immunological barrier involving secretory IgA and specialized immune cells (Vancamelbeke & Vermeire, 2017, PMID: 28650209). Its fundamental biological function is to selectively allow the absorption of nutrients, water, and electrolytes while preventing the translocation of harmful pathogens, toxins, and dietary antigens into the systemic circulation (Okumura & Takeda, 2017, PMID: 28546564). Dysfunction of this barrier, often characterized by increased permeability or "leaky gut," is a central feature in the pathogenesis of inflammatory bowel disease (IBD), celiac disease, and various metabolic disorders (Groschwitz & Hogan, 2009, PMID: 19560575). Therapeutic interventions targeting these components include tight junction regulators like larazotide acetate, which aims to restore barrier integrity, and mucosal protectants or growth factors like teduglutide that promote epithelial repair.
Modulation of tight junction permeability, stimulation of mucus secretion, enhancement of epithelial cell proliferation, and regulation of mucosal immune responses.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal barrier components (IMB).